Peringkat dalam Saham
#42192
GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced... GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases). The company's portfolio includes treatments for a variety of these conditions, such as COVID-19, and illnesses like paratuberculosis (Johne's disease), currently in its Stage III clinical phase, as well as mad cow and chronic wasting diseases, and common bacterial infections like E.coli and salmonella. Furthermore, GeneThera is developing a vaccine specifically targeting Mycobacterium avium subspecies paratuberculosis bacteria. Utilizing its innovative Molecular Robotic/AI Platform and a strategic therapeutic framework, the company strives to inhibit the spread of animal-borne diseases and improve control over zoonotic infectious agents. GeneThera, Inc. operates out of Westminster, Colorado.
Harga Saham
$0.0001
Terakhir disinkronkan: 2025-03-10
Kapitalisasi Pasar
$3.53K
Perubahan (1 tahun)
0.00%
Perdagangan GeneThera, Inc. (GTHR)
Harga GTHR dengan kapitalisasi pasar B
Kapitalisasi pasar dari GeneThera, Inc.(GTHR)
Kapitalisasi Pasar: $3.53K
Per August 2026, GeneThera, Inc. memiliki kapitalisasi pasar sebesar $3.53K. Ini menjadikan GeneThera, Inc. sebagai perusahaan 42192nd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar GeneThera, Inc. dari 2012 hingga 2026
GTHR dibandingkan dengan 5 teratas stocks paling populer
| Harga GTHR |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.383T
|
+152,373,604,768.38%
|
|
|
|
|
$4.423T
|
+125,202,128,508.49%
|
|
|
|
|
$4.160T
|
+117,757,412,837.50%
|
|
|
|
|
$3.663T
|
+103,688,673,463.54%
|
|
|
|
|
$2.891T
|
+81,834,950,236.82%
|
